Women exposed to synthetic estrogen diethylstilbestrol (DES) in the womb face increased cancer risk, study finds
A study of daughters of women given diethylstilbestrol, synthetic estrogen, during pregnancy has found that exposure to the drug while in the womb is associated with many reproductive problems and an increased risk of certain cancers. Beginning in 1940, DES was used to prevent certain pregnancy complications, but was later found to be ineffective in the 1950s. In the 1960s, a rare cancer of the vagina in young women was linked to DES exposure.
- Prenatal exposure to BPA and DES may increase breast cancer riskFri, 28 May 2010, 18:39:17 EDT
- Prenatal exposure to endocrine-disrupting chemicals linked to breast cancerFri, 21 May 2010, 11:51:27 EDT
- Pregnancy associated with increased risk of heart attackMon, 7 Jul 2008, 17:36:10 EDT
- Anti-estrogen drug therapy reduces risk of invasive breast cancer in older womenTue, 10 Jun 2008, 21:49:44 EDT
- Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapyMon, 13 Jul 2009, 12:43:20 EDT